Top

Gepubliceerd in:

01-01-2013 | Special Article

Pregnancy in women with hypertrophic cardiomyopathy

Auteurs: P. G. Pieper, F. Walker

Gepubliceerd in: Netherlands Heart Journal | Uitgave 1/2013

Abstract

Hypertrophic cardiomyopathy (HCM) is increasingly being diagnosed in pregnant women. Women with HCM generally tolerate pregnancy well. The risk is however higher in women who are symptomatic before pregnancy or in those with severe left ventricular outflow tract obstruction. The incidence of arrhythmias does not appear to be increased during pregnancy and maternal mortality is low. Prior to conception, women with HCM should have a risk assessment as well as genetic counselling. During pregnancy beta-blockers should be continued and the judicious use of diuretics may be required to treat symptoms of dyspnoea. A vaginal delivery with regional anaesthesia is usually appropriate. Women should be managed by a specialist multidisciplinary team.

vorige artikel Myocardial bridging: what have we learned in the past and will new diagnostic modalities provide new insights?

volgende artikel Quality of life research, it’s only the beginning

Verheugt CL, Uiterwaal CSPM, van der Velde ET, et al. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010;96:872–8.PubMedCrossRef

Drenthen W, Boersma E, Balci A, et al. On behalf of the ZAHARA investigators. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J. 2010;31:2124–32.PubMedCrossRef

Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29:270–6.PubMedCrossRef

Christiaans I, Nannenberg EA, Dooijes D, et al. Founder mutations in hypertrophic cardiomyopathy in the Netherlands. Neth Heart J. 2010;18:248–54.PubMedCrossRef

Christiaans I, Birnie E, Bonsel GJ, et al. Manifest disease, risk factors for sudden cardiac death, and cardiac events in a large nationwide cohort of predictively tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy. Eur Heart J. 2011;32:1161–70.PubMedCrossRef

Van den Wijngaard A, Volders P, van Tintelen JP. Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Neth Heart J. 2011;19:344–51.PubMedCrossRef

Ommen SR. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 2011;36:409–53.PubMedCrossRef

Ho CY. Hypertrophic cardiomyopathy in 2012. Circ. 2012;125:1432–8.CrossRef

Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2011;142:e153–203.PubMedCrossRef

10.

Krul SPJ, Smagt JJ, van den Berg MP, et al. Systematic review of pregnancy in women with inherited crdiomyopathies. Eur J Heart Fail. 2011;13:584–94.PubMedCrossRef

11.

Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology. Eur Heart J. 2011;32:3147–97.PubMedCrossRef

12.

Van Langen IM, Arens Y, Baars H, et al. ICIN working group on Hereditary Heart Diseases. Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM). Neth Heart J. 2010;18:144–59.CrossRef

13.

Pieper PG. Pre-pregnancy risk assessment and counseling of the cardiac patient. Neth Heart J. 2011;19:477–81.PubMedCrossRef

14.

Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515–21.PubMedCrossRef

15.

Autore C, Conte MR, Piccinno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40:1864–9.PubMedCrossRef

16.

Thaman R, Varnava A, Hamid MS, et al. Pregnancy related complications in women with hyprtrophic cardiomyopathy. Heart. 2003;89:752–6.PubMedCrossRef

17.

Avila WS, Amaral FMC, Ramires JAF, et al. Influence of pregnancy on clinical course and fetal outcome of women wit hypertrophic cardiomyopathy. Arq Bras Cardiol. 2007;88:423–8.CrossRef

18.

Schuler PK, Herrey A, Wade A, et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace 2012; doi:10.1093/europace/eus172.

19.

Tromp CHN, Nanne ACM, Pernet PJM, et al. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011;19:134–6.PubMedCrossRef

20.

Pieper PG. The pregnant woman with heart disease: management of pregnancy and delivery. Neth Heart J. 2012;20:33–7.PubMedCrossRef

21.

Walker D, Kaur N, Bell R, et al. Hypertrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. Minerva Anestesiol. 2007;73:485–586.PubMed

22.

Ferguson EA, Paech MJ, Veltman MG. Hypertrophic cardiomyopathy and caesarean section: intraoperative use of transthoracic echocardiography. Int J Obst Anesth. 2006;15:311–6.CrossRef

Titel: Pregnancy in women with hypertrophic cardiomyopathy
Auteurs: P. G. Pieper
F. Walker
Publicatiedatum: 01-01-2013
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 1/2013
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-012-0358-7

Andere artikelen Uitgave 1/2013

The effect of aortic valve replacement on quality of life in symptomatic patients with severe aortic stenosis

Original Article – E-LEARNING

Quality of life among patients with severe aortic stenosis

Original Article

Ruptured sinus of Valsalva aneurysm association with bicuspid aortic valve

Open Access
Imaging in Cardiology

Palpitations, once again

Rhythm Puzzle - Question

Quality of life research, it’s only the beginning

Editorial Comment

Beta-blocker therapy in unstable severe heart failure, evidence or experience?

Point of View